Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DEXLANSOPRAZOLE Cause Dysphonia? 56 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Dysphonia have been filed in association with DEXLANSOPRAZOLE (Dexlansoprazole). This represents 0.2% of all adverse event reports for DEXLANSOPRAZOLE.

56
Reports of Dysphonia with DEXLANSOPRAZOLE
0.2%
of all DEXLANSOPRAZOLE reports
0
Deaths
10
Hospitalizations

How Dangerous Is Dysphonia From DEXLANSOPRAZOLE?

Of the 56 reports, 10 (17.9%) required hospitalization, and 2 (3.6%) were considered life-threatening.

Is Dysphonia Listed in the Official Label?

Yes, Dysphonia is listed as a known adverse reaction in the official FDA drug label for DEXLANSOPRAZOLE.

What Other Side Effects Does DEXLANSOPRAZOLE Cause?

Chronic kidney disease (15,973) Acute kidney injury (7,599) Renal failure (6,618) End stage renal disease (4,800) Renal injury (4,320) Tubulointerstitial nephritis (2,177) Death (1,417) Rebound acid hypersecretion (1,160) Gastrooesophageal reflux disease (1,013) Drug ineffective (859)

What Other Drugs Cause Dysphonia?

FLUTICASONE\SALMETEROL (1,729) CABOZANTINIB S-MALATE (1,229) ADALIMUMAB (1,216) BUDESONIDE\FORMOTEROL (1,204) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (1,143) ALBUTEROL (1,114) LENVATINIB (1,021) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (943) LENALIDOMIDE (931) AMIKACIN (914)

Which DEXLANSOPRAZOLE Alternatives Have Lower Dysphonia Risk?

DEXLANSOPRAZOLE vs DEXMEDETOMIDINE DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE\SERDEXMETHYLPHENIDATE DEXLANSOPRAZOLE vs DEXPANTHENOL DEXLANSOPRAZOLE vs DEXRAZOXANE

Related Pages

DEXLANSOPRAZOLE Full Profile All Dysphonia Reports All Drugs Causing Dysphonia DEXLANSOPRAZOLE Demographics